3234 Results

People

  1. Ladanyi
    Ladanyi
  2. Offit
    Offit
  3. Antonescu
    Antonescu
  4. Berger
    Berger
  5. Schultz
    Schultz
  6. Abdel-Wahab
    Abdel-Wahab
  7. Levine
    Levine
  8. Reis-Filho
    Reis-Filho
  9. Robson
    Robson
  10. Weigelt
    Weigelt

Groups

  1. GSK Faculty (1395)
  2. Department of Medicine (1218)
  3. Solid Tumor Oncology Division (813)
  4. Sloan Kettering Institute Postdocs (767)
  5. Sloan Kettering Institute Faculty (736)
  6. Department of Pathology and Laboratory Medicine (678)
  7. Tow Center for Developmental Oncology (TCDO) (448)
  8. Human Oncology and Pathogenesis Program (437)
  9. Center for Hematologic Malignancies (426)
  10. Hematologic Malignancies, Division of (416)
  1. "genetics"
Formats
  1. Journal Article (2772)
  2. Review (219)
  3. Editorial (99)
  4. Research Letter (39)
  5. Conference Paper (27)
  6. Guidelines (27)
  7. Correspondence (16)
  8. Book Section (15)
  9. Meeting Abstract (11)
  10. Miscellaneous (8)
  11. Book Whole (1)
Groups
  1. GSK Faculty (1395)
  2. Department of Medicine (1218)
  3. Solid Tumor Oncology Division (813)
  4. Sloan Kettering Institute Postdocs (767)
  5. Sloan Kettering Institute Faculty (736)
  6. Department of Pathology and Laboratory Medicine (678)

More Groups

People
  1. Marc Ladanyi (96)
  2. Kenneth Offit (88)
  3. Cristina Antonescu (72)
  4. Michael Berger (72)
  5. Nikolaus Schultz (67)
  6. Omar Abdel-Wahab (65)

More People

Years
  1. 2025 (181)
  2. 2024 (554)
  3. 2023 (507)
  4. 2022 (439)
  5. 2021 (41)
  6. 2020 (40)

More Years

Publications
  1. Clinical Cancer Research (123)
  2. Nature Communications (121)
  3. Journal of Clinical Oncology (103)
  4. Nature (76)
  5. Blood (69)
  6. Proceedings of the National Academy of Sciences of the United States of America (67)

More Publications

Publishers
  1. Nature Publishing Group (477)
  2. American Association for Cancer Research (260)
  3. Cell Press (180)
  4. Oxford University Press (141)
  5. Springer (136)
  6. Elsevier Inc. (135)

More Publishers

Results (3234)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CRISPR dependency screens in primary hematopoietic stem cells identify KDM3B as a genotype-specific vulnerability in IDH2- and TET2-mutant cells
    Journal Article

    Waarts, M. R.; Mowla, S.; Boileau, M.; Martinez Benitez, A. R.; Sango, J.; Bagish, M.; Fernández-Maestre, I.; Shan, Y.; Eisman, S. E.; Park, Y. C.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • Distinct tumor architectures and microenvironments for the initiation of breast cancer metastasis in the brain
    Journal Article

    Gan, S.; Macalinao, D. G.; Shahoei, S. H.; Tian, L.; Jin, X.; Basnet, H.; Bibby, C.; Muller, J. T.; Atri, P.; Seffar, E.; more...
    Cancer Cell (2024)

    Fulltext@MSK | Save
  • Prediction of homologous recombination deficiency from routine histology with attention-based multiple instance learning in nine different tumor types
    Journal Article

    Loeffler, C. M. L.; El Nahhas, O. S. M.; Muti, H. S.; Carrero, Z. I.; Seibel, T.; van Treeck, M.; Cifci, D.; Gustav, M.; Bretz, K.; Gaisa, N. T.; more...
    BMC Biology (2024)

    Fulltext@MSK | Save
  • Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes
    Research Letter

    Lue, J. K.; Luttwak, E.; Rivas-Delgado, A.; Irawan, H.; Boardman, A.; Caron, P. C.; David, K.; Epstein-Peterson, Z.; Falchi, L.; Ghione, P.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Microhomology-mediated end-joining chronicles: Tracing the evolutionary footprints of genome protection
    Review

    Sfeir, A.; Tijsterman, M.; McVey, M.
    Annual Review of Cell and Developmental Biology (2024)

    Fulltext@MSK | Save
  • Precision oncology: Current and future platforms for treatment selection
    Review

    Tang, X.; Berger, M. F.; Solit, D. B.
    Trends in Cancer (2024)

    Fulltext@MSK | Save
  • Cooperative genomic lesions in HRAS-mutant cancers predict resistance to farnesyltransferase inhibitors
    Journal Article

    Nigam, A.; Krishnamoorthy, G. P.; Chatila, W. K.; Berman, K.; Saqcena, M.; Walch, H.; Venkatramani, M.; Ho, A. L.; Schultz, N.; Fagin, J. A.; more...
    Oncogene (2024)

    Fulltext@MSK | Save
  • Obscure DNA sequences unveil a new cancer target
    Editorial

    Sfeir, A.
    Nature Structural and Molecular Biology (2024)

    Fulltext@MSK | Save
  • Engineering immune-evasive allogeneic cellular immunotherapies
    Review

    Martin, K. E.; Hammer, Q.; Perica, K.; Sadelain, M.; Malmberg, K. J.
    Nature Reviews Immunology (2024)

    Fulltext@MSK | Save
  • Precision therapeutics and emerging strategies for HR-positive metastatic breast cancer
    Review

    Lloyd, M. R.; Jhaveri, K.; Kalinsky, K.; Bardia, A.; Wander, S. A.
    Nature Reviews Clinical Oncology (2024)

    Fulltext@MSK | Save